Clinical trial · Observational
Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment
Outcome of Multidisciplinary Education Programme in Self-care in Fatigue Lung Cancer Patients Who Receiving Chemotherapy Treatment
NCT01546233CI-TRIAL-00022882completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare the fatigue in lung cancer patients receiving chemotherapy treatment, between the education programme in self-care a multidisciplinary with the group who received standard care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| multidisciplinary education programme | Behavioral | — | UNRESOLVED |
| standard education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- multidisiplinary self care program
- description
- Patient with Lung cancer will be participated in group education with multidisiplinary self care program
- interventionNames
- Behavioral: multidisciplinary education programme
- label
- Conventional education
- description
- Lung cancer patient will be received standard education
- interventionNames
- Behavioral: standard education
Primary outcomes (1)
- measure
- Measure fatigue by questionnaires
- timeFrame
- August 2011 to august 2012 (up to 1 year)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: 1. Aged 45-65 years. 2. Has been diagnosed lung cancer stages 3-4 must be chemotherapy is platinum-based, and had received chemotherapy for at least one time, must be in the range of 2-4 cycles of chemotherapy. 3. Performance status: ECOG 0-1 4. No problem hearing it. 5. Read and write Thai. 6. Be willing to cooperate in research. And signed a joint research Exclusion Criteria: 1. The complications include: high fever, severe nausea and vomiting. 2. Injection drug use in diabetes treatment. 3. Ischemic heart disease with heart arrhythmia and the drug continuously. 4. Is unable to daily living. Caused by defects in movement, and severe osteoarthritis, muscle atrophy, paralysis or walking flat less than 10 meters.
References
Publications (0)
Data not yet available
No reference posted for this study.